Literature DB >> 12124457

Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad.

Masaharu Takahashi1, Tsutomu Nishizawa1, Akira Yoshikawa2, Shin Sato3, Norio Isoda3, Kenichi Ido3, Kentaro Sugano3, Hiroaki Okamoto1.   

Abstract

Two distinct hepatitis E virus (HEV) isolates, designated HE-JI3 and HE-JI4, were identified in a single patient with acute hepatitis in Japan, who had not travelled abroad. The HEV load of HE-JI3 at admission was 10(2) copies/ml, but that of HE-JI4 was tenfold higher at 10(3) copies/ml. The viraemia of HE-JI4 persisted for up to 16 days from admission, whereas HE-JI3 disappeared at 9 days after admission. The entire nucleotide sequence of the HE-JI4 isolate and partial nucleotide sequences of open reading frames (ORFs) 1 and 2 of the HE-JI3 isolate were determined. The full-length nucleotide sequence of HE-JI4 consisted of 7171 nucleotides excluding the poly(A) tail and contained ORF1 encoding 1684 amino acids, ORF2 encoding 671 amino acids and ORF3 encoding 114 amino acids. Sequence and phylogenetic analyses of the HEV genomes indicated that HE-JI4 was most closely related to an HEV isolate (T1) of genotype IV with the same strategy for translation of ORF2 and ORF3, but which differed from it by 16.5% over the entire genome. The HE-JI3 isolate showed the highest nucleotide identity (88.6-95.1%) to the genotype III HEVs, having higher identity to human and swine HEV isolates from the United States (US1, US2 and swUS1) than to those reported thus far from Japan (JRA1 and swJ570). The two co-infecting strains of HE-JI3 and HE-JI4 identified from the single patient shared only 80.1% nucleotide identity. These results indicate that multiple genotypes of HEV co-circulate in Japan, and that genotype IV comprises a remarkably heterogeneous group of HEVs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124457     DOI: 10.1099/0022-1317-83-8-1931

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Evidence of recombination between divergent hepatitis E viruses.

Authors:  Hélène van Cuyck; Jun Fan; David L Robertson; Pierre Roques
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Hepatitis E infection during pregnancy.

Authors:  Shahnaz A Chaudhry; Natasha Verma; Gideon Koren
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

Review 3.  Clinical features and determinants of chronicity in hepatitis E virus infection.

Authors:  Shivakumar Narayanan; Ameer Abutaleb; Kenneth E Sherman; Shyam Kottilil
Journal:  J Viral Hepat       Date:  2019-02-05       Impact factor: 3.728

4.  Hepatitis E virus and serum level aminotransferases in blood donors.

Authors:  Abdolreza Sotoodeh Jahromi; Morteza Pourahmad
Journal:  Rep Biochem Mol Biol       Date:  2013-10

Review 5.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection.

Authors:  Masaharu Takahashi; Shigeyuki Kusakai; Hitoshi Mizuo; Kazuyuki Suzuki; Kuniko Fujimura; Kazuo Masuko; Yoshiki Sugai; Tatsuya Aikawa; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 7.  Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection.

Authors:  Lisa J Krain; Jessica E Atwell; Kenrad E Nelson; Alain B Labrique
Journal:  Am J Trop Med Hyg       Date:  2014-01-13       Impact factor: 2.345

8.  Identification of 5' capped structure and 3' terminal sequence of hepatitis E virus isolated from Morocco.

Authors:  Guo-Bing Chen; Ji-Hong Meng
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

Review 9.  Molecular biology and pathogenesis of hepatitis E virus.

Authors:  Vivek Chandra; Shikha Taneja; Manjula Kalia; Shahid Jameel
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

10.  Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo.

Authors:  R S Pudupakam; Y W Huang; T Opriessnig; P G Halbur; F W Pierson; X J Meng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.